In order to ensure the cuts in GST (goods and services tax) rates of essential Covid-19 drugs and other medications is passed on to consumers, the National Pharmaceutical Pricing Authority has directed all pharma manufacturing and marketing companies to revise the maximum retail price (MRP) on drugs and formulations immediately taking into effect the reduced tax rate.
The move from the pharma pricing regulator is expected to ensure that the tax cuts benefit consumers by way of low cost of drugs and medications in the current difficult period of the pandemic.
The office memorandum issued by NPPA said that the change in GST rate has an impact on fixation of MRP of items attracting tax. As the MRP of drugs and formulations is inclusive of tax, therefore, any downward change in tax/GST rates should be reflected in MRP and the benefit of this reduction should be passed on to the consumers, it said.
The Authority has, however, said that recalling or relabelling or test ticketing on the label of the container or pack of relaxed sticks on the market prior to the date of notifications, is not mandatory, if manufacturers are able to ensure price compliance at the retailer level, through issuance of a revised price list.
The NPPA directions followed queries raised by manufacturers and marketing companies regarding implementation of MRP on drugs.
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.
Corona Virus (COVID-19) Latest Updates
30 June 2021
At 817, India records least deaths since 10th April
India reported 45,951 new Covid-19 cases and 817 deaths in the last 24 hours, according to data released by the Union Health and Family Welfare Ministry on...
Newborn Calf Serum Is Used Only for Growth of Vero Cells for Making Covaxin: Govt, Bharat Biotech Clarify
Moneylife Digital Team
16 June 2021
Refuting rumours spread by some social media posts about the use of newborn calf serum in Covaxin, the Union government on Wednesday clarified that the coronavirus (COVID) vaccine manufactured by Bharat Biotech Ltd, does not contain...
Daily Covid cases down 79%, active cases 65%: Health Ministry
15 June 2021
There has been sharp decline in both new and active Covid-19 cases across India for the last few days, the Union Health Ministry said on Tuesday.
Addressing a digital press conference on current situation, Joint Secretary,...
Only 27% succeeded in getting vax appointment on CoWIN in last 7 days: LocalCircles Survey
11 June 2021
Only 27 per cent of those who tried to get Covid vaccine appointment on the CoWIN/Aarogya Setu app in the last seven days were able to do so, said a survey by LocalCircles.
The survey sought to understand the magnitude of...